DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

125.54 -1.91 (-1.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIO $125.54 -1.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $127.06
Previous Close $127.45
Daily Range $124.89 - $128.55
52-Week Range $115.90 - $152.38
Market Cap $3.7B
P/E Ratio 36.31
Dividend (Yield) $0.00 (0.0%)
Volume 127,040
Average Daily Volume 104,697
Current FY EPS $3.44





Bio-Rad Laboratories, Inc. (BIO) Description

The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components. Website:

News & Commentary Rss Feed

Can Investors Gain from the New Age in Medical Testing?

A new age in medical testing may be dawning. Improvements in genetic analysis could revolutionize the way disease is treated. Can investors in participating companies like Illumina, Myriad Genetics and Bio-Rad Labs gain from this momentous transformation?

Fluidigm's Q4 Preliminary Results Fail to Woo Investors

Notable Wednesday Option Activity: BIO, SYNA, DGI

BIO Makes Bullish Cross Above Critical Moving Average

FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing

The Santa Claus Rally Is Coming

It Is Time To Short Bio-Rad

Bio-Rad Laboratories (BIO) Norman D. Schwartz on Q3 2015 Results - Earnings Call Transcript

Bio-Rad Laboratories (BIO) Q3 2015 Results - Earnings Call Webcast

It Is Time To Short BIO-Rad Laboratories, Inc.

Premarket Biotech Digest: Cancer Facts, Progenics' Relistor, Roche On Biotech Bubble

See More BIO News...

BIO's Top Competitors

BIO $125.54 (-1.50%)
Current stock: BIO
TMO $123.18 (-3.62%)
Current stock: TMO
ILMN $136.05 (-5.11%)
Current stock: ILMN
WAT $115.47 (-2.08%)
Current stock: WAT